Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce.
Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year – the highest number since the 1,967 seen in 2021.
Medications to treat epilepsy and cystic fibrosis are among those that pharmacists are finding it hard or impossible to get hold of, creating risks for patients’ health.
The figures have emerged in a new report by the Nuffield Trust health thinktank, which obtained them under freedom of information laws from the DHSC, which oversees the availability of drugs UK-wide.
Mark Dayan, a policy analyst at the Nuffield Trust and its Brexit programme lead, said: “This wave of medicine shortages has already meant people struggle to find the drugs their doctors told them were needed for conditions like epilepsy and cystic fibrosis. It’s very worrying that it appears to be rolling on at full force into a third year.”
The report says that while drug shortages have become a problem globally in recent years, the UK is facing “a worsening situation” compared with the rest of Europe because of Brexit.
“Elevated and troubling levels of medicine shortages are continuing, with no consistent sign of improvement. The UK has had the lowest import growth in medicines of any G7 country, driven by a reduction in EU imports,” the thinktank adds.
Source: The Guardian, 22 March 2025
Related reading on the hub:
- Medicines shortages: minimising the impact on patients (a blog by Catherine Picton)
- Medication supply issues: A pharmacist’s perspective
- Medication supply issues: Mast cell activation syndrome (MCAS)
Share on the hub your experiences of medication shortages: Medication supply issues: have you been affected?
Recommended Comments
Create an account or sign in to comment